The choice between a biostimulator (a collagen-stimulating treatment) and a filler depends on which tissue is responsible for the change you see in your face. You may come across the same treatment names while researching a hollow in your cheek, added lip volume, or sagging along your jawline. During the examination, we first distinguish between these changes. The volume provided by a hyaluronic acid filler gel, the support a biostimulator aims to achieve through a tissue response, and the repositioning of tissue through surgery are different interventions.
To understand your options, it helps to know where a material will be used and for what purpose, as well as its name. PLLA (poly-L-lactic acid) and calcium hydroxylapatite (CaHA) are substances we use to stimulate collagen; calcium hydroxylapatite also has a gel carrier that provides volume. Here, we explain what these properties mean for filler selection, how they relate to Botox, and why surgery may be considered for pronounced sagging. At your consultation, you can describe the change you would like in your own words and ask which finding in your face the proposed treatment addresses.
How biostimulators and fillers work differently
Hyaluronic acid is a molecule that can retain water and is also found in connective tissue. We place a gel formulated for use as a filler into the tissue to add volume and shape. For example, if you would like a more defined lip border or greater chin projection, we focus on the position and shape of the gel to be added. This goal relates to the space the material physically occupies.
Biostimulator treatment focuses on the response of cells involved in collagen production. Collagen is a protein that contributes to the strength of connective tissue; the cells that produce it are called fibroblasts. The intended response around biostimulator particles targets the tissue’s own supporting structure. The treatment does not involve injecting ready-made collagen.
For this reason, fillers and biostimulators should not be viewed as two entirely separate categories covering all materials. Calcium hydroxylapatite combines the volume support of its gel carrier with the collagen-stimulating function of its particles. To understand a recommendation, you can ask how the material is prepared and which tissue layer it targets, as well as what it contains. Our biostimulators page explains their use for tissue support in detail.
Volume loss and skin elasticity are also separate characteristics. There may be fine folds in the skin while cheek fullness is preserved, or a hollow at the temple without pronounced skin folds. Each of these findings changes what an injection is intended to address.
How do PLLA and calcium hydroxylapatite differ?
PLLA is a particulate material that is mixed with liquid to prepare it for injection. We choose where to place the preparation according to skin thickness and the need for support beneath it. The volume occupied by the preparation liquid in the tissue differs from the collagen response the particles are intended to stimulate. Describing PLLA solely by the amount of liquid injected therefore does not explain the purpose of the treatment.
In calcium hydroxylapatite, microspheres, or very small round particles, are suspended in a gel carrier. The carrier gel provides volume support, while the response around the microspheres is directed toward collagen production. These properties receive different emphasis when supporting an area along the jawline and when treating the structure of the neck skin. This explains why the same material can be prepared and distributed in different ways.
Hyperdilute calcium hydroxylapatite refers to treatment with a substantially diluted preparation. The aim is to address the skin’s supporting structure over a wider area. Adding volume at a specific point and addressing skin structure on the neck or upper chest require different patterns of distribution. We choose the concentration and target layer according to the overlying tissue in that area.
When choosing between PLLA and calcium hydroxylapatite, we do not assume that the same material will be used throughout the face. The extent of a hollow at the temple, the fat tissue in the cheek, and skin movement along the jawline are separate findings. The reason for a choice can be explained in relation to the volume present in each area and the supporting structure being targeted.
Which options are considered for each facial area?
At the temples and cheeks, we look at whether hollowing affects a narrow transition or a broad area. The volume of the fat compartments beneath the skin and the thickness of the overlying skin influence whether a filler or biostimulator is considered. Wanting a more defined cheek contour and addressing widespread loss of support in the same area are different goals. As we examine your face from the front and side, we can show you where each goal applies.
Hyaluronic acid fillers may be considered for lip volume and border definition. The movement of the lips during speech and smiling is taken into account when choosing the gel’s properties. PLLA and calcium hydroxylapatite are generally unsuitable for adding lip volume or treating thin eyelid tissue. A material used in the cheeks cannot be assumed suitable for every part of the face.
Under the eyes, shadows caused by hollowing, the skin’s own color, prominent fat tissue, and excess skin are assessed separately. A filler may be considered for the part of the appearance related to a lack of volume. We do not regard darkness around the eyes alone as an indication for filler. When planning dermal fillers, the area’s overlying tissue and surrounding structures are as relevant as the properties of the gel.
When considering biostimulators for the neck, upper chest, or backs of the hands, we assess thin skin and the need for underlying volume separately. A horizontal neck crease and a muscle band beneath the skin are different structures. On the backs of the hands, thin overlying tissue and volume loss may also be present to different degrees; the material and layer chosen for the face do not automatically apply to this area.
Can biostimulators and fillers be part of the same plan?
We can include biostimulators and fillers in the same treatment plan when different tissues in the face have different needs. For example, someone who would like to change their lip shape may also have widespread loss of support in the cheeks. Adding volume with a gel in the lips and targeting a collagen response in the cheeks are explained according to the anatomy of each area. Recommending one treatment does not mean the other is necessarily needed.
When deciding what to do in each area, we also examine the distribution of tissue on the right and left sides of the face. A pronounced hollow on one side may not cover the same area on the other. Volume in neighboring areas also affects where support is added. We therefore describe the goal for the lips, cheeks, or jawline separately, rather than explaining the plan solely through the total amount of material.
If you have had fillers before, you can share any treatment records you have. Knowing which material was placed in which area helps us interpret existing fullness. It is also useful to mention any treatment whose contents you do not know. The tissue felt during the examination and information about previous procedures are taken into account when selecting a new material.
Your general health is also part of material selection. Cosmetic filler and biostimulator treatments are postponed during pregnancy and breastfeeding, and injections are not performed in areas with an active infection. If you have a known allergy to an ingredient or an immune system disorder, the nature of the condition and the treatments used are reviewed separately. A diagnosis of an immune system disorder does not lead to the same suitability decision for everyone.
When describing your expectations, you can distinguish between wanting your face to look fuller and wanting to change a particular contour. Chin projection, sagging along the jawline, and cheek hollowing are separate concerns. Discussing them at the same consultation does not mean that every area will receive an injection.
Where does Botox fit among these options?
Botox (botulinum toxin) is a treatment intended to reduce the contraction of facial expression muscles. For horizontal forehead lines and lines between the eyebrows or at the outer corners of the eyes that become more visible with movement, we examine how the muscles work. Adding volume with a filler and targeting a collagen response with a biostimulator involve different mechanisms from muscle movement. The scope of Botox treatment depends on how a line changes with facial expression.
Muscle movement, skin structure, and volume loss can contribute to different degrees to a line visible when your face is at rest. We therefore observe the same area as you frown, raise your eyebrows, and smile. An expression line at the outer corner of the eye and a hollow beneath it are close together but involve different tissues. The name of an area alone does not determine which treatment to choose.
If Botox, fillers, and biostimulators are included in the same plan, we explain the aim of each separately. A forehead line that appears with movement, lip volume, and loss of cheek support are examples of this distinction. You can tell us which facial expressions you would like to preserve; we use these expectations to shape the muscle treatment plan and the volume plan.
The role of a facelift in pronounced sagging
If tissue has descended below the jawline or there is extensive excess skin on the neck, tissue position also needs to be examined. Adding volume by injection does not remove this skin. Collagen stimulation with a biostimulator does not involve surgically repositioning cheek tissue that has moved downward, either. When these findings are pronounced, we explain which areas a face and neck lift could address.
A facelift involves working on the supporting layers and removing excess skin. The same person may also have volume loss in the cheeks. Sagging and hollowing next to each other therefore do not necessarily call for the same method. During the examination, we describe fine folds on the skin’s surface, a lack of volume beneath it, and tissue that has moved downward separately.
Researching a nonsurgical option does not mean that you have to choose surgery. If you have pronounced excess skin, understanding the scope of injections can help you weigh your options. Knowing which anatomical feature a proposed procedure cannot change can help your decision as much as knowing which procedure you would like.
Frequently asked questions
Do biostimulators add volume throughout the face?
A biostimulator plan is limited to the material chosen and the treatment area. With PLLA, the collagen response is considered; with calcium hydroxylapatite, the gel carrier’s support is considered alongside that response. The same volume or treatment goal is not intended for every part of the face.
Can a biostimulator be used instead of a lip filler?
PLLA and calcium hydroxylapatite are generally unsuitable for adding lip volume. For lip shaping, the properties of hyaluronic acid gels are chosen according to the mobile lip tissue and the desired contour. A treatment considered for cheek support is not automatically suitable for the lips.
Does someone who has a biostimulator treatment need Botox?
The need for Botox depends on a separate finding related to the movement of facial expression muscles. Having a biostimulator treatment does not create a need for Botox or replace an examination of the muscles. Changes in forehead or outer eye lines with movement are assessed in their own right.
Does age or skin structure determine biostimulator selection?
Skin thickness, the nature of laxity, and the distribution of volume loss guide the choice. Different areas and tissue layers may need attention in people of the same age. General health and previous treatments also inform the decision.
How is a decision made if the material in an old filler is unknown?
If the material is unknown, that uncertainty is taken into account in the new treatment plan. Any available records are reviewed for the treatment area and material used. If there are no records, you can explain which area was treated; the existing tissue is examined by touch and from different angles.
